http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2104217-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1992-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ac305765dfb0ec8c0765ae220643e9f |
| publicationDate | 1992-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2104217-A1 |
| titleOfInvention | Treatment of endotoxemia |
| abstract | Disclosed is a method for treating endotoxemia and other types of infection by gram-negative or similar pathogens. The method includes providing a therapeutic agent that is a non-immunoglobulin polypeptide, soluble in the circulation, and has the ability to bind endotoxin-related substances; and administering to the circulation of a subject a therapeutic amount of the agent. This conjugate has reduced toxicity and reduced pathogenicity relative to unconjugated endotoxin-related substances. In preferred embodiments, the therapeutic agent is at least a portion of the extracellular portion of the scavenger receptor protein. |
| priorityDate | 1991-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.